NCT00556816

Brief Summary

COPD (chronic obstructive pulmonary disease) is a chronic disease which is increasing. Patients with COPD are the most important concern of the pulmonologists. At the outpatient clinic has been observed that the amount of new and regular COPD patients is of such a size that it seems to overwhelm the capacity of the outpatient clinic. Solutions could be substitution of medical care, longer intervals between the appointments or discharge from secondary medical care to primary care. The first point does not solve the lack of capacity, the second point is not allowed because it will decrease quality of care and transition of care is a temporary solution. COPD is a complex disease, whereby, and certainly in an advanced stadium, multidisciplinary and qualified expertise is needed. The optimal control frequency of patients with COPD is unknown. COPD is a disease with fluctuating activity and complaints over time. There is a chance that patients are seen at a stable state at the regular outpatient clinical visits instead of moments when medical care is obligated. The regular management of the outpatient clinic will therefore result in an ineffective treatment of COPD patients. In this way general practitioners and even patients could suggest that visits to the outpatient pulmonary clinic are confounding less to a good treatment of COPD. Outpatient clinical care on demand, initiated by patients in other chronic patient groups like rheumatoid arthritis and inflammatory bowel diseases, are proven to be safe and effective leading to less consumption and costs of medical care in comparison to standard outpatient clinical visits 2-5. The outpatient clinical care on demand for COPD is not figured out yet. Our aim is to investigate whether this special type of outpatient clinical care is effective in the management of COPD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Sep 2007

Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 12, 2007

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

September 18, 2015

Status Verified

September 1, 2015

Enrollment Period

4.1 years

First QC Date

November 9, 2007

Last Update Submit

September 17, 2015

Conditions

Keywords

COPDoutpatient on demand clinic

Outcome Measures

Primary Outcomes (1)

  • change in health status (CCQ)

    2 years

Secondary Outcomes (3)

  • use of medical care (visits to GP, ER, outpatient clinic)

    2 years

  • quality of life (SGRQ and SF-36)

    2 years

  • the number of appointments with the pulmonary nurse/ nurse practitioner

    2 years

Study Arms (2)

Conventional outpatient clinic

ACTIVE COMPARATOR

Conventional outpatient clinic

Behavioral: Control

On demand outpatient clinic

EXPERIMENTAL

On demand outpatient clinic

Behavioral: on demand clinic

Interventions

Outpatient on demand clinic

On demand outpatient clinic
ControlBEHAVIORAL

conventional outpatient clinic

Conventional outpatient clinic

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD patients at least GOLD II (FEV1 \< 70%, FEV1/VC ratio \< 70%)
  • age \> 40 years
  • smoking history \> 10 pack years
  • informed consent

You may not qualify if:

  • significant or instable comorbidity
  • a history of asthma
  • drug or alcohol abuse
  • incapacity to fill in questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Isala Klinieken

Zwolle, 8011 JW, Netherlands

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • L.N. Boom, Drs.

    Isala

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 9, 2007

First Posted

November 12, 2007

Study Start

September 1, 2007

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

September 18, 2015

Record last verified: 2015-09

Locations